Imfinzi Combo Shows Survival Boost in Bladder Cancer: NIAGARA Trial
AstraZeneca’s Imfinzi, combined with chemotherapy, excels in enhancing survival for muscle-invasive bladder cancer patients, marking a pivotal advance in perioperative care. The NIAGARA Phase III trial underscores Imfinzi's potential to redefine treatment standards by curbing recurrence post-cystectomy without surgical compromise.
- #general surgery
- #pharmacology
- #general medicine
- #psych
- #rheumatology
- #pathology
- #radiology
- #anaesthesia
- #psychiatry
- #fmt
- #emergency medicine
- #academics
- #nursing
- #pharmacy
- #trichology
- #andrology
- #orthopaedics
- #critical care
- #dermatology
- #dentistry
- #oncology
- #business
- #gastroenterology
- #nephrology
- #diagnostics
- #urology
- #ophthalmology
- #gynaecology - ivf
- #pediatrics
- #neurology
- #ent
- #pulmonology
- #family health
- #cardiology
- #endo-diabetology